EXHIBIT 10.2 BRIDGE VENTURES, INC. 1241 Gulf of Mexico Dr. Longboat Key, Florida 34228 CONSULTING AGREEMENT THE CONSULTING AGREEMENT ("Agreement") is made this 1st day of August 1997, by and between Bridge Ventures, Inc.] (the "Consultant") whose...Consulting Agreement • March 3rd, 2000 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
EXHIBIT 10.3 SAGGI CAPITAL CORP. 545 Madison Avenue New York New York 10022 CONSULTING AGREEMENT THE CONSULTING AGREEMENT ("Agreement") is made this 1st day of August 1997, by and between Saggi Capital Corp. (the "Consultant") whose principal place of...Consulting Agreement • March 3rd, 2000 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
EXHIBIT 10.6 CONFIDENTIALITY AGREEMENT - EMPLOYEE CONFIDENTIALITY AGREEMENT THIS AGREEMENT is entered into by ("Employee") and Elite Laboratories, Inc. ("Elite") this _____ day of ________________, 199____. RECITALS A. Employee is an employee of...Confidentiality Agreement • March 3rd, 2000 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • Delaware
EXHIBIT 4.2 FORM OF WARRANT AGREEMENT NUMBER WARRANTS ELITE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANTS CUSIP 28659T 127 THIS CERTIFIES THAT _______________ IS THE OWNER OF ___________ OR REGISTERED ASSIGNS, IS ENTITLED TO PURCHASE ONE FULLY...Warrant Agreement • March 3rd, 2000 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations
OR REGISTERED ASSIGNS, IS ENTITLED TO PURCHASE ONE FULLY PAID AND NONASSESSABLE SHARE OF ELITE PHARMACEUTICALS, INC., A DELAWARE CORPORATION (HEREIN CALLED THE COMPANY) FOR EACH WARRANT EVIDENCED BY THIS CERTIFICATE FOR $6.00 PER SHARE DURING THE PERIOD COMMENCING UPON THE FIRST DAY THAT THE COMMON STOCK TRADES AND EXPIRING NOVEMBER 30, 2002, UPON ITS SURRENDER, AND PAYMENT OF THE PURCHASE PRICE AT THE AGENTS OFFICE, 201 BLOOMFIELD AVE., VERONA, NEW JERSEY 07044 SUBJECT TO THE FOLLOWING CONDITIONS: 1. THE EXERCISE PRICE IS PAYABLE IN CASH, CERTIFIED CHECK OR BANK DRAFT; 2. ADJUSTMENTS IN THE EXERCISE PRICE OR NUMBER OF SHARES ISSUABLE WILL BE MADE FOR STOCK SPLITS, RECAPITALIZATION, MERGER, CONSOLIDATION OR OTHER EVENT AFFECTING WARRANT HOLDERS INTEREST, ADJUSTMENTS FOR THE STATED EVENT WILL MAINTAIN THE WARRANT HOLDER'S SAME RELATIVE POSITION TO THE COMPANY AS EXISTED PRIOR TO EXERCISE. 3. WARRANT EXERCISE REQUIRES APPROPRIATE COMPLETION OF THE "ELECTION TO PURCHASE" PRINTED ON THE BA
EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS AGREEMENT is entered into this 28th day of December 1995, by and between Elite Laboratories, Inc., a Delaware corporation (hereinafter "ELITE") and Atul M. Mehta of Ramsey, New Jersey (hereinafter "MEHTA")....Employment Agreement • March 3rd, 2000 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations
EXHIBIT 10.5 CONFIDENTIALITY AGREEMENT - CORPORATION CONFIDENTIALITY AGREEMENT NON-DISCLOSURE AGREEMENT Elite Laboratories, Inc. of 230 W. Passaic Street, Maywood, New Jersey 07607, a Delaware corporation (hereinafter referred to as "ELITE") have in...Confidentiality Agreement • March 3rd, 2000 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations
